Life Biosciences Stock
Life Biosciences is a developer of drugs designed to promote longevity and find treatments for age-related diseases.
Sign up today and learn more about Life Biosciences Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Life Biosciences Stock
Life Biosciences is a developer of drugs designed to promote longevity and find treatments for age-related diseases. Developer of drugs designed to promote longevity and find treatments for age-related diseases. The company's drugs help to combat the eight pathways of age-related decline and it's work addresses health decline due to aging as a systemic breakdown of the body, rather than a series of isolated events and conditions, enabling senior citizens to tackle age-related diseases with a view to ultimately extending healthy life spans.
Funding History
| January 2019 | $50.0M |
|---|---|
| May 2020 | $74.8M |
| January 2022 | $82.0M |
Management
Chief Executive Officer
Mehmood Khan
CIO
Tristan Edwards
Head Of Research & Development
Joan Mannick
Board Member
Bracken Darrell
Head, Intellectual Property Strategy
Frances Toneguzzo
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
